Rare Disease

Rare Disease

Inflammation is a recognized cause of Neurodegeneration.

November 21st, 2019 | Rare Disease

Neuroinflammation is inflammation of the nervous tissue. It may be initiated in response to a variety of cues, including infection, traumatic brain injury, toxic metabolites, or autoimmunity. In the  CNS, including the brain and spinal cord, microglia are the resident innate immune cells that are activated in response to these cues. The CNS is typically an immunologically privileged site because peripheral […]

Biologic treatments show promise in providing clinical solutions to a variety of diseases. Boston Biotech Clinical Research has experience in biologics for rare diseases and can help develop a targeted strategy for your needs.

October 31st, 2019 | Rare Disease

Biologic treatments show promise in providing clinical solutions to a variety of diseases Due to biological’s unique characteristics, study designers may find that results in pre-clinical trials do not predict acute, chronic and late onset immunogenicity and safety. In Addition, the biological orphan has a long PK half-life of months such as with any mAb, […]

Do Not Make Mistakes!

September 30th, 2019 | Rare Disease

Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?

July 24th, 2019 | Rare Disease

Gene Therapy for Rare Disorders Europe 2019 – October 15th – 17th, London

July 15th, 2019 | Rare Disease

Drug development success hinges on simplifying Clinical Research

May 16th, 2019 | Rare Disease

Strategic Consulting: The convergence revolution to innovate clinical trial process

May 10th, 2019 | Rare Disease

Strategic Consulting – SCIO Process -A New Way for Drug Development

April 30th, 2019 | Rare Disease

Strategic consulting reduces cost and risk of clinical trials

April 2nd, 2019 | Rare Disease

SCIO Helps Early Stage Biotech Company Evaluation

January 24th, 2019 | Rare Disease

Pin It on Pinterest